Tristel PLC
LSE:TSTL
Intrinsic Value
Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. [ Read More ]
The intrinsic value of one TSTL stock under the Base Case scenario is 452.08 GBX. Compared to the current market price of 470 GBX, Tristel PLC is Overvalued by 4%.
Valuation Backtest
Tristel PLC
Run backtest to discover the historical profit from buying and selling TSTL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Tristel PLC
Current Assets | 22.1m |
Cash & Short-Term Investments | 10.8m |
Receivables | 6.9m |
Other Current Assets | 4.5m |
Non-Current Assets | 18.7m |
PP&E | 8.4m |
Intangibles | 9.7m |
Other Non-Current Assets | 626k |
Current Liabilities | 4.5m |
Accounts Payable | 3.7m |
Other Current Liabilities | 814k |
Non-Current Liabilities | 5.2m |
Long-Term Debt | 5.1m |
Other Non-Current Liabilities | 48k |
Earnings Waterfall
Tristel PLC
Revenue
|
39.5m
GBP
|
Cost of Revenue
|
-6.9m
GBP
|
Gross Profit
|
32.6m
GBP
|
Operating Expenses
|
-26.4m
GBP
|
Operating Income
|
6.2m
GBP
|
Other Expenses
|
-139k
GBP
|
Net Income
|
6m
GBP
|
Free Cash Flow Analysis
Tristel PLC
TSTL Profitability Score
Profitability Due Diligence
Tristel PLC's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Tristel PLC's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
TSTL Solvency Score
Solvency Due Diligence
Tristel PLC's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
Tristel PLC's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TSTL Price Targets Summary
Tristel PLC
According to Wall Street analysts, the average 1-year price target for TSTL is 487.82 GBX with a low forecast of 424.2 GBX and a high forecast of 551.25 GBX.
Shareholder Return
TSTL Price
Tristel PLC
Average Annual Return | 10.42% |
Standard Deviation of Annual Returns | 27.18% |
Max Drawdown | -56% |
Market Capitalization | 222.7m GBX |
Shares Outstanding | 47 495 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.
Contact
IPO
Employees
Officers
The intrinsic value of one TSTL stock under the Base Case scenario is 452.08 GBX.
Compared to the current market price of 470 GBX, Tristel PLC is Overvalued by 4%.